Clinical Trial Update: Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating checkpoint inhibitor combination therapy as first-line treatment for inoperable lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Lung Cancer, Inoperable Disease | Phase 2 | Status: RECRUITING